A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cancer Prevention Research

• Publication date

  2018-02-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1940-6207.CAPR-17-0354PMID 29453232PMCID PMC6290902
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Menopause Is a Determinant of Breast Aromatase Expression and Its Associations With BMI, Inflammation, and Systemic Markers

  2017cited by this paper
• Very-long-chain ω-3 fatty acid supplements and adipose tissue functions: a randomized controlled trial.

  2017cited by this paper
• Risk Factors That Increase Risk of Estrogen Receptor–Positive and –Negative Breast Cancer

  2017cited by this paper
• Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNFα

  2016cited by this paper
• Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal Women

  2015cited by this paper
• Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer

  2015influential reference
• Menopause Is a Determinant of Breast Adipose Inflammation

  2015influential reference
• Obesity and cancer: local and systemic mechanisms.

  2015cited by this paper
• Docosahexaenoic acid differentially affects TNFα and IL-6 expression in LPS-stimulated RAW 264.7 murine macrophages.

  2015cited by this paper
• Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women

  2015cited by this paper
• limma powers differential expression analyses for RNA-sequencing and microarray studies

  2015cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• What we talk about when we talk about fat.

  2014cited by this paper
• voom: precision weights unlock linear model analysis tools for RNA-seq read counts

  2014cited by this paper
• Adipose tissue foam cells are present in human obesity.

  2013cited by this paper
• n3 PUFAs do not affect adipose tissue inflammation in overweight to moderately obese men and women.

  2013cited by this paper
• Food-frequency questionnaire for assessing long-chain ω-3 fatty-acid intake: Re: Assessing long-chain ω-3 polyunsaturated fatty acids: a tailored food-frequency questionnaire is better.

  2013cited by this paper
• Determinants of Erythrocyte Omega‐3 Fatty Acid Content in Response to Fish Oil Supplementation: A Dose–Response Randomized Controlled Trial

  2013cited by this paper
• Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients.

  2013cited by this paper
• HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma

  2013cited by this paper
• Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies

  2013cited by this paper
• Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older Americans.

  2012cited by this paper
• Obesity Is Associated with Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland

  2011cited by this paper
• Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer

  2011influential reference
• Global cancer statistics

  2011cited by this paper
• Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.

  2010cited by this paper
• Macrophages, inflammation, and insulin resistance.

  2010cited by this paper
• Specialty Supplements and Breast Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort

  2010cited by this paper
• Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation.

  2010cited by this paper
• Measurement of organochlorines in commercial over-the-counter fish oil preparations: implications for dietary and therapeutic recommendations for omega-3 fatty acids and a review of the literature.

  2009cited by this paper
• Effect of tumor necrosis factor-alpha on estrogen metabolism and endometrial cells: potential physiological and pathological relevance.

  2009cited by this paper
• Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation.

  2009cited by this paper
• A simple sample size formula for analysis of covariance in randomized clinical trials.

  2007cited by this paper
• Distribution, interconversion, and dose response of n-3 fatty acids in humans.

  2006cited by this paper
• TLR4 links innate immunity and fatty acid-induced insulin resistance.

  2006cited by this paper
• Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice.

  2006cited by this paper
• Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n−3 polyunsaturated fatty acids

  2006cited by this paper
• Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200

  2005cited by this paper
• Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone.

  2005cited by this paper
• Docosahexaenoic acid-enriched egg consumption induces accretion of arachidonic acid in erythrocytes of elderly patients.

  2004cited by this paper
• Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy.

  2004cited by this paper
• Dietary factors protective against breast cancer in Japanese premenopausal and postmenopausal women

  2003cited by this paper
• Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish?

  2003cited by this paper
• Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: The Singapore Chinese Health Study

  2003cited by this paper
• Mercury and the risk of coronary heart disease in men.

  2002cited by this paper
• Omega-3 fatty acids as cancer chemopreventive agents.

  1999cited by this paper
• The effect of dietary docosahexaenoic acid on plasma lipoproteins and tissue fatty acid composition in humans

  1997cited by this paper
• Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis.

  1994cited by this paper
• Fish consumption and breast cancer risk: an ecological study.

  1989cited by this paper

• Safety and efficacy of docosahexaenoic acid supplementation during neoadjuvant breast cancer therapy: Findings from the phase II, double‐blind, randomized controlled DHA‐WIN trial

  2025cites this paper
• The Impact of Polyunsaturated Fatty Acids in Cancer and Therapeutic Strategies

  2025cites this paper
• Omega-3 world map: 2024 update.

  2024cites this paper
• Self-assembled lipid-based nanoparticles for chemotherapy against breast cancer

  2024cites this paper
• Re-Assessing the Role of Platelet Activating Factor and Its Inflammatory Signaling and Inhibitors in Cancer and Anti-Cancer Strategies.

  2024cites this paper
• Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance

  2024cites this paper
• The Effects of Omega-3 Fatty Acids Supplementation on Inflammatory Factors in Cancer Patients: A Systematic Review and Dose-Response Meta-Analysis of Randomized Clinical Trials

  2023influential citation
• Leptin: A Heavyweight Player in Obesity-Related Cancers

  2023cites this paper
• Pharmaceutical nanoformulation strategies to spatiotemporally manipulate oxidative stress for improving cancer therapies — exemplified by polyunsaturated fatty acids and other ROS-modulating agents

  2022cites this paper
• Role of adipocyte browning in prostate and breast tumor microenvironment

  2022cites this paper
• Obesity as a Risk Factor for Breast Cancer—The Role of miRNA

  2022cites this paper
• Omega-3 Polyunsaturated Fatty Acids and Cancer

  2021cites this paper
• Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

  2021cites this paper
• Current Landscape: The Mechanism and Therapeutic Impact of Obesity for Breast Cancer

  2021cites this paper
• Change in Blood and Benign Breast Biomarkers in Women Undergoing a Weight-Loss Intervention Randomized to High-Dose ω-3 Fatty Acids versus Placebo

  2021cites this paper
• Docosahexaenoic acid (DHA) and linoleic acid (LA) modulate the expression of breast cancer involved miRNAs in MDA-MB-231 cell line.

  2021cites this paper
• Role of the Sterol Regulatory Element Binding Protein Pathway in Tumorigenesis

  2020cites this paper
• The Effect of Omega-3 Polyunsaturated Fatty Acid Supplementations on anti-Tumor Drugs in Triple Negative Breast Cancer

  2020cites this paper
• Customized Prevention Trials Could Resolve the Controversy of the Effects of Omega-3 Fatty Acids on Cancer

  2020cites this paper
• Effects of omega-3 fatty acids supplementation on neoadjuvant chemotherapy-induced toxicity in patients with locally advanced breast cancer: a randomized, controlled, double-blinded clinical trial.

  2019influential citation
• Docosahexaenoic Acid (DHA)

  2019cites this paper
• The Conundrum of Omega-3 Fatty Acids in Cancer Prevention Studies: Which One? How Much? What Biomarkers?

  2018influential citation